Novan Announces SB204 Program Update Conference Call and Webcast
Mar 03, 2017 21:05 pm UTC| Business
MORRISVILLE, N.C., March 03, 2017 -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Monday, Mar. 6, at 8 a.m. Eastern Time to provide an update on...
Applied Optoelectronics Announces Completion of At the Market Offering
Mar 03, 2017 21:03 pm UTC| Business
SUGAR LAND, Texas, March 03, 2017 -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, fiber-to-the-home (FTTH) and...
Aspen Group to Announce Fiscal 2017 3rd Quarter Results on Thursday, March 9th
Mar 03, 2017 21:01 pm UTC| Business
NEW YORK, March 03, 2017 -- Aspen Group, Inc. (OTCQB:ASPU), parent of Aspen University, a nationally accredited online postsecondary education company, will host a conference call to discuss its fiscal year 2017 third...
FutureFuel to Release Year-End 2016 Financial Results on March 16
Mar 03, 2017 21:01 pm UTC| Business
CLAYTON, Mo. , March 03, 2017 -- FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release year-end 2016 financial results after...
Mar 03, 2017 20:58 pm UTC| Business
NEW YORK, March 03, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Galena Biopharma, Inc. securities (NASDAQ:GALE) from August 11,...
Middlesex Water Company Announces 2016 Fourth Quarter and Year-End Results
Mar 03, 2017 20:55 pm UTC| Business
ISELIN, N.J., March 03, 2017 -- Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ:MSEX) today reported financial results for the fourth quarter and year ended December 31, 2016. Highlights Net Income of...
Cellceutix Provides Update on Developing p53 Drug Candidate Kevetrin as an Oral Anti-Cancer Agent
Mar 03, 2017 20:50 pm UTC| Business
BEVERLY, Mass., March 03, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...